I agree that this site is using cookies. You can find further informations here.
X
huishou, Fan
56  results:
Search for persons X
?
1

Clinical Characteristics, Survival Outcomes and prognosis i..:

Jiahui, Liu ; huishou, Fan ; Xuehan, Mao...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e304 , 2019
Link: https://doi.org/10.1016/..
 
?
2

IgH translocations with undefined partners are associated w..:

Mao, xuehan ; Xu, Yan ; Yan, yuting...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e82-e83 , 2019
Link: https://doi.org/10.1016/..
 
?
3

The impact of response kinetics following initial therapy f..:

Yan, yuting ; Mao, xuehan ; Jiahui, Liu...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e222-e223 , 2019
Link: https://doi.org/10.1016/..
 
?
4

Multiple high-risk cytogenetic aberrations confer a progres..:

Mao, xuehan ; Xu, Yan ; Yan, yuting...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e83 , 2019
Link: https://doi.org/10.1016/..
 
?
5

The prognostic impact of dynamic changing of cytogenetic ab..:

huishou, Fan ; Jiahui, Liu ; Xuehan, Mao...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e221-e222 , 2019
Link: https://doi.org/10.1016/..
 
?
6

The prognostic value of 1q21 gain does not rely on the copy..:

Du, Chenxing ; An, gang ; Xu, Yan...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e62-e63 , 2019
Link: https://doi.org/10.1016/..
 
?
7

Monitoring Minimal Residual Disease in Patients with Multip..:

Fan, Huishou ; Wang, Bing ; Shi, Lihui...
Clinical Cancer Research.  30 (2024)  6 - p. 1131-1142 , 2024
Link: https://doi.org/10.1158/..
 
?
8

Longitudinal genetically detectable minimal residual diseas..:

Cui, Jian ; Yu, Tengteng ; Lv, Rui...
Therapeutic Advances in Medical Oncology.  16 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
9

MAF translocation remains a strong prognostic factor despit..:

Liu, Yuntong ; Lv, Rui ; Yan, Wenqiang...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
10

Identification of therapy-induced clonal evolution and resi..:

Cui, Jian ; Li, Xiaoyun ; Deng, Shuhui...
Clinical Cancer Research.  , 2024
Link: https://doi.org/10.1158/..
 
?
11

Development and validation of an individualized and weighte..:

Mao, Xuehan ; Yan, Wenqiang ; Mery, David...
American Journal of Hematology.  99 (2024)  4 - p. 523-533 , 2024
Link: https://doi.org/10.1002/..
 
?
12

P-174 Early relapse within 18 months (ER18) is a powerful d..:

Yan, Wenqiang ; Xu, Jingyu ; Fan, Huishou..
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S131 , 2023
Link: https://doi.org/10.1016/..
 
?
13

P-327 Hyposecretory progression pattern indicates inferior ..:

Xu, Jingyu ; Yan, Wenqiang ; Fan, Huishou..
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S219 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Prognostic value of the Second Revision of the Internationa..:

Yan, Wenqiang ; Fan, Huishou ; Xu, Jingyu...
Chinese Medical Journal.  136 (2023)  14 - p. 1744-1746 , 2023
Link: https://doi.org/10.1097/..
 
?
15

Impact of residual tumor cells in the stem cell collection ..:

Xu, Jingyu ; Yan, Wenqiang ; Fan, Huishou...
Annals of Hematology.  102 (2023)  11 - p. 3195-3204 , 2023
Link: https://doi.org/10.1007/..
 
1-15